LATEST UPDATES » Vol 26, Nos. 09 & 10, September & October 2022 – Toxins and Medicines – Two Sides of the Same Coin       » Utilising Metal Nanoparticles as Plant Growth Regulators to Improve Crop Yield       » Remedy or Poison? How Microplastics Influence Copper Ion Toxicity in Aquatic Plants       » Synthesising Schiff Base Antimicrobial Copper Complexes With Unprecedented Speed       » Enhancing the Understanding of Past Infections With Machine Learning       » Mini, Cellular Bioweapons: Understanding the Structure and Mechanism of Stinging in Sea Anemone Nematocysts       » Converting Dead Spiders Into Gripping Tools
Vol 26, Nos. 09 & 10, September & October 2022   |   Issue PDF view/purchase
Generating Nanoparticle Mists from Solutions with Plasma for Medical Use
Researchers have found a safe way to generate a mist of nano-sized particles using plasma, which has the potential to be utilised in novel methods for transdermal drug delivery.

In recent years, the field of plasma medicine has been attracting interest as a novel therapy in medicine. It centres around atmospheric pressure plasma – one of the four fundamental states of matter, comprising charged, free-moving particles – and its direct effects, which include heat, and chemically reactive species which may be applied to targeted areas of the body. However, the limitations of current technologies only allow for the use of plasma to treat lesions and wounds externally, and more fine-tuning to pre-existing technologies has to be done before they may be used in internal medicine.

;Fortunately, a team of researchers from the Tokyo University of Agriculture and Technology has found a way to create a nano-sized mist using plasma, which may have potential uses in internal medicine. Their findings were published in ;Scientific Reports ;on June 22.

Plasma is currently used to address burns and wounds and may also be used as a precise tool to remove benign skin lesions. Other technologies involving plasma include transdermal drug delivery systems where the skin is exposed to plasma. If the concept is to be further extended beyond transdermal drug delivery and into drug delivery to other internal organs, a nano-sized approach is required.

If the nanoparticles could be generated directly from a solution of the drug instead, targeted drug delivery within the body would be made much easier. This might be made possible using plasma, as nano-sized particles generated by it allow drugs to cross the skin and other tissue barriers with greater ease and reach the target area intact.

Thus, the researchers developed a biologically safe way to use plasma to create the nano-sized mist from various types of solutions. By passing the solutions through a dielectric barrier discharge, mists from polar and non-polar solvents were obtained. The electrical conductivity of the solution was observed to be a key factor in affecting the rate at which the mist was generated. ;

The method they developed to create the mist makes use of two charged electrodes that sandwich a dielectric (also known as an insulator), which is more commonly used in the manufacturing industry. This method is safer and more convenient than the alternative electrostatic spray method to generate nanoparticle mists as it does not require high voltages and grounding of the target, reducing the likelihood of a potentially fatal electric shock.

The increased safety of the method to generate nanoparticle mists allows for the potential expansion of their use in biological systems. “We have succeeded in developing a technology to generate nano-sized mist by passing liquid through a dielectric barrier discharge at low velocity. This technology is safer than the conventional electrostatic spray, which is used in the industrial field,” said Daisuke Yoshino, associate professor at the Tokyo University of Agriculture and Technology. “Ultimately, we aim to apply our technology to biomedical fields, such as transdermal drug delivery systems.”

Source: Watanabe et al. (2022). Potential generation of nano-sized mist by passing a solution through dielectric barrier discharge. ;Scientific Reports, ;12(1), 1-10.

What Has Covid Ever Done for Us?
news 2022 PDA Aseptic Processing of Biopharmaceuticals Conference
news Thailand LAB INTERNATIONAL, Bio Asia Pacific, and FutureCHEM INTERNATIONAL are ready to offer the Science and Technology Industry complete solutions this September!
news Better together: registration opens for Vitafoods Asia 2022 co-located with Fi Asia in October
news 2022 PDA Pharmaceutical Manufacturing & Quality Conference

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   [email protected] or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   [email protected]
Copyright© 2022 World Scientific Publishing Co Pte Ltd  •  Privacy Policy